The development of effective combined anti-retroviral therapy (cART) led to a significant
reduction in the death rate associated with human immunodeficiency virus type 1 (HIV-1) …

HIV-1 has evolved mechanisms to evade host cell immune responses and persist for lifelong
infection. Latent cellular reservoirs are responsible for this persistence of HIV-1 despite the …

HIV/AIDS is still a global threat despite the notable efforts made by the scientific and health
communities to understand viral infection, to design new drugs or to improve existing ones …

Recognition of cell-surface receptors and co-receptors is a crucial molecular event towards
the establishment of HIV infection. HIV exists as several variants that differentially recognize …

More than 80 million people worldwide have been infected with the human
immunodeficiency virus (HIV). There are now approximately 39 million individuals living with …

Tuberculosis owes its resurgence as a major global health threat mostly to the emergence of
drug resistance and coinfection with HIV. The synergy between HIV and Mycobacterium …

Ongoing with current combinations of antiretroviral drugs for the treatment of Human
Immunodeficiency Virus (HIV) infection can successfully maintain long-term suppression of …

The HIV-1 often evades a robust antiretroviral-mediated immune response, leading to
persistent infection within anatomically privileged sites including the CNS. Continuous low …

Although antiretroviral therapy (ART) has drastically changed the lives of people living with
human immunodeficiency virus-1 (HIV-1), long-term treatment has been associated with a …

The current use of combined antiretroviral therapy (cART) is leading to a significant
decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 …